Immunic, Inc. (NASDAQ:IMUX) Q4 2023 Earnings Call Transcript

Immunic, Inc. (NASDAQ:IMUX) Q4 2023 Earnings Call Transcript February 22, 2024

Immunic, Inc. beats earnings expectations. Reported EPS is $-0.48, expectations were $-0.51. IMUX isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here).

Jessica Breu: Good morning to everybody on the line. I would like to welcome you to Immunic’s Fourth Quarter and Year End 2023 Earnings Call. My name is Jessica Breu, Vice President, Investor Relations and...